STOCK TITAN

Vanguard disaggregates holdings; INGN shows 0 shares (INGN)

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

The Vanguard Group filed Amendment No. 10 to a Schedule 13G/A reporting zero beneficial ownership of Inogen Inc common stock. The filing states an Amount beneficially owned: 0 and Percent of class: 0% as reported in the amendment dated 03/13/2026. The filing explains an internal realignment and disaggregation of Vanguard subsidiaries in accordance with SEC Release No. 34-39538 (January 12, 1998), noting certain subsidiaries now report separate beneficial ownership. The signature on the amendment is dated 03/27/2026 and is signed by Ashley Grim, Head of Global Fund Administration.

Positive

  • None.

Negative

  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: On January 12, 2026, The Vanguard Group, Inc. went through an internal realignment. In accordance with SEC Release No. 34-39538 (January 12, 1998), certain subsidiaries or business divisions of subsidiaries of The Vanguard Group, Inc., that formerly had, or were deemed to have, beneficial ownership with The Vanguard Group, Inc., will report beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc. in reliance on such release. These subsidiaries and/or business divisions pursue the same investment strategies as previously pursued by The Vanguard Group, Inc. prior to the realignment. Further in accordance with SEC Release No. 34-39538 (January 12, 1998), The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by such subsidiaries and/or business divisions.


SCHEDULE 13G



The Vanguard Group
Signature:Ashley Grim
Name/Title:Head of Global Fund Administration
Date:03/27/2026

FAQ

What does The Vanguard Group report for INGN in this Schedule 13G/A amendment?

The filing reports 0 shares beneficially owned and 0% of the class for Inogen Inc common stock as of 03/13/2026. It reflects Vanguard's disaggregated reporting after an internal realignment under SEC guidance.

Why does Vanguard state separate reporting for subsidiaries in the amendment?

Vanguard cites SEC Release No. 34-39538 (January 12, 1998), saying certain subsidiaries or business divisions will report beneficial ownership separately following an internal realignment completed on January 12, 2026.

Who signed the Schedule 13G/A amendment for INGN and when?

The amendment is signed by Ashley Grim, Head of Global Fund Administration. The signature line shows the date 03/27/2026, attesting to the reported information in the amendment.

Does the amendment identify any other person with more than 5% ownership in INGN?

The filing states that no other person's interest reported herein is more than 5%. It also notes Vanguard-managed accounts have rights to dividends or proceeds but no single outside person exceeds the five percent threshold.

What voting or dispositive powers does Vanguard report for INGN shares?

The amendment reports 0 for sole voting power, shared voting power, sole dispositive power, and shared dispositive power regarding Inogen Inc common stock, consistent with the reported 0 shares beneficially owned.
Inogen Inc

NASDAQ:INGN

View INGN Stock Overview

INGN Rankings

INGN Latest News

INGN Latest SEC Filings

INGN Stock Data

177.01M
23.86M
Medical Devices
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Link
United States
BEVERLY